Anticoagulation treatment in atrial fibrillation;Antikoagulasjonsbehandling ved atrieflimmer

Tidsskrift for den Norske Laegeforening

Volumn 122, Issue 2, 2002, Pages 191-192

  Gjesdal, Knut ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; DISEASE PREDISPOSITION; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; PREVALENCE; RISK ASSESSMENT; SHORT SURVEY; STROKE; THROMBOEMBOLISM; ARTICLE; DRUG CONTRAINDICATION;

ANTICOAGULANTS; ATRIAL FIBRILLATION; HUMANS; THROMBOEMBOLISM; WARFARIN;

EID: 0037138131     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (11)

1. Epidemilogic assessment of atrial fibrillation and risk of stroke: The Framingham study
2. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with non-valvular artrial fibrillation
3. Silent cerebral infarction in chronic atrial fibrillation
4. Embolic complications in paroxysmal atrial fibrillation
5. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials
6. Comparison of bleeding complications of warfarin and warfarin plus acetylsalicylic acid: A study in 3 166 outpatients
7. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation
8. Antikoagulationsbehandling
9. New-onset atrial fibrillation. Sex differences in presentation, treatment, and outcome
10. Bättre AVK-terapi med egenkontroll. Dosen kan justeras i tid
11. ACC/AHA/ESC guidelines for the management of atrial fibrillation